Similar to mast cells and MDSCs, TANs are mostly recruited from the blood, so blocking the CXCR4-CXCL12 pathway will help inhibit the recruitment of TANs to tumor tissue [130]. The gene discussed is CXCL12; the disease is neoplasm.